Lectin‐affinity chromatography brain glycoproteomics and Alzheimer disease: Insights into protein alterations consistent with the pathology and progression of this dementing disorder

No abstract is available for this paper.

• Publication year

  2011

• Venue

  PROTEOMICS - Clinical Applications

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/prca.201000070PMID 21280237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluorodeoxyglucose Positron Emission Tomography Studies in Presumed Alzheimer Cases, Including 13 Serial Scans

  2014cited by this paper
• Molecular Pathology of Alzheimer's Disease

  2013cited by this paper
• Human Alzheimer’s disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Glycoproteomics in neurodegenerative diseases.

  2010cited by this paper
• 2010 Alzheimer's disease facts and figures

  2010cited by this paper
• Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

  2009influential reference
• Siglec receptors and hiding plaques in Alzheimer's disease

  2009cited by this paper
• Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism

  2009cited by this paper
• In Vivo Modulation of O-GlcNAc Levels Regulates Hippocampal Synaptic Plasticity through Interplay with Phosphorylation*

  2009cited by this paper
• Proteomics by mass spectrometry: approaches, advances, and applications.

  2009cited by this paper
• Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

  2009influential reference
• Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis

  2008cited by this paper
• Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease

  2007cited by this paper
• Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder

  2007cited by this paper
• Phosphorylation Blocks the Activity of Tubulin Polymerization-promoting Protein (TPPP)

  2007cited by this paper
• Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins

  2007cited by this paper
• Isolation of N-linked glycopeptides from plasma.

  2007cited by this paper
• Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.

  2007cited by this paper
• Concurrent alterations of O‐GlcNAcylation and phosphorylation of tau in mouse brains during fasting

  2006cited by this paper
• Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.

  2006cited by this paper
• ELKS, a protein structurally related to the active zone protein CAST, is involved in Ca2+‐dependent exocytosis from PC12 cells

  2006cited by this paper
• Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1

  2006cited by this paper
• Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

  2005cited by this paper
• Alzheimer's disease: Abeta, tau and synaptic dysfunction.

  2005cited by this paper
• Alzheimer's disease: Aβ, tau and synaptic dysfunction

  2005cited by this paper
• Physical and functional interaction of the active zone proteins, CAST, RIM1, and Bassoon, in neurotransmitter release

  2004cited by this paper
• Mitogen-activated protein kinases in synaptic plasticity and memory.

  2004cited by this paper
• Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S

  2004cited by this paper
• O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

  2004cited by this paper
• MCI conversion to dementia and the APOE genotype

  2004cited by this paper
• Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column.

  2004cited by this paper
• Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases

  2004cited by this paper
• Faculty Opinions recommendation of Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

  2003cited by this paper
• Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

  2003cited by this paper
• Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5.

  2002cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET)

  2001cited by this paper
• Glycoprotein identification and localization of O-glycosylation sites by mass spectrometric analysis of deglycosylated/alkylaminylated peptide fragments.

  2001cited by this paper
• Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry

  2001cited by this paper
• Piccolo, a presynaptic zinc finger protein structurally related to bassoon.

  2000cited by this paper
• Simultaneous detection and identification of O-GlcNAc-modified glycoproteins using liquid chromatography-tandem mass spectrometry.

  2000cited by this paper
• Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity

  1999cited by this paper
• Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

  1999cited by this paper
• Mass spectrometric determination of the sites of O-glycan attachment with low picomolar sensitivity.

  1998cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

  1997cited by this paper
• ALTERATIONS IN THE O-LINKED GLYCOSYLATION OF IgA1 IN CHILDREN WITH HENOCH-SCHONLEIN PURPURA. • 1848

  1997cited by this paper
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

  1996cited by this paper
• Candidate gene for the chromosome 1 familial Alzheimer's disease locus

  1995cited by this paper
• A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

  1995cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• Pathological proteins in senile plaques.

  1994influential reference
• Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas.

  1994cited by this paper
• Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation.

  1993cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications.

  1992cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper
• Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PET a

  1991cited by this paper
• Cortical Glutaminase, β-Glucuronidase and Glucose Utilization in Alzheimer's Disease

  1989cited by this paper
• Hepatoesplenomegalia de etiologia desconocida : abordaje clinico para su diagnostico en 57 casos

  1989cited by this paper
• [Hepatosplenomegaly of unknown etiology: clinical examination in making a diagnosis in 57 cases].

  1989cited by this paper
• Carbohydrate binding properties of complex-type oligosaccharides on immobilized Datura stramonium lectin.

  1987cited by this paper
• Crosslinked concanavalin A-O-(diethylaminoethyl)-cellulose--an affinity medium for concanavalin A-interacting glycoproteins.

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Binding and functional properties of concanavalin A and its derivatives. III. Interactions with indoleacetic acid and other hydrophobic ligands.

  1978cited by this paper
• Peanut agglutinin, a new mitogen that binds to galactosyl sites exposed after neuraminidase treatment.

  1975cited by this paper
• Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding.

  1974cited by this paper
• Restriction of the mobility of lymphocyte immunoglobulin receptors by concanavalin A.

  1972cited by this paper
• PROTEIN-CARBOHYDRATE INTERACTION. II. INHIBITION STUDIES ON THE INTERACTION OF CONCANAVALIN A WITH POLYSACCHARIDES.

  1965cited by this paper

• Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers

  2024cites this paper
• Advances in protein glycosylation and its role in tissue repair and regeneration

  2023cites this paper
• Lectin-Based Affinity Enrichment and Characterization of N-Glycoproteins from Human Tear Film by Mass Spectrometry

  2023cites this paper
• Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer’s disease

  2021cites this paper
• COSMC mutations reduce T‐synthase activity in advanced Alzheimer's disease

  2020cites this paper
• Differential effects of putative N-glycosylation sites in human Tau on Alzheimer’s disease-related neurodegeneration

  2020cites this paper
• Deciphering the causal relationship between blood metabolites and Alzheimers Disease: a Mendelian Randomization study

  2020cites this paper
• Emerging Trends of Biotechnology in Marine Bioprospecting: A New Vision

  2020cites this paper
• Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s disease

  2020cites this paper
• Protein Glycosylation: An Important Tool for Diagnosis or Early Detection of Diseases

  2019cites this paper
• The Role of Pictorial Cigarette Pack Warnings on the Attitude and Behavior of Smokers

  2019cites this paper
• Multilayered N-glycoproteome profiling reveals highly heterogeneous and dysregulated protein N-glycosylation related to Alzheimer's disease.

  2019cites this paper
• An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer's disease.

  2019cites this paper
• Lifetime cognition and late midlife blood metabolites: findings from a British birth cohort

  2018cites this paper
• Plasma Glycoproteomic Study of Therapeutic Hypothermia Reveals Novel Markers Predicting Neurologic Outcome Post-cardiac Arrest

  2018cites this paper
• The Role of Omics in Clinical and Pharmaceutical Researches

  2018cites this paper
• Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila.

  2017cites this paper
• Interplay between protein glycosylation pathways in Alzheimer’s disease

  2017cites this paper
• LW-AFC Effects on N-glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer’s Disease

  2017cites this paper
• Glycosylation patterns and PHA-E-associated glycoprotein profiling associated with early hepatic encephalopathy in Chinese hepatocellular carcinoma patients.

  2016cites this paper
• In-depth mapping of the mouse brain N-glycoproteome reveals widespread N-glycosylation of diverse brain proteins

  2016cites this paper
• Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.

  2016cites this paper
• "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.

  2015cites this paper
• Cell Surface Nucleolin Facilitates Enterovirus 71 Binding and Infection

  2015cites this paper
• The role of protein glycosylation in Alzheimer disease

  2014cites this paper
• The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

  2014cites this paper
• The 2013 Discovery Award from the Society for Free Radical Biology and Medicine : Selected Discoveries from the Butterfield Laboratory of Oxidative Stress and Its Sequelae in Brain in Cognitive Disorders Exemplified by Alzheimer Disease and Chemotherapy Induced Cognitive Impairment

  2014cites this paper
• Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.

  2014cites this paper
• The Effects of Endogenous Non-Peptide Molecule Isatin and Hydrogen Peroxide on Proteomic Profiling of Rat Brain Amyloid-β Binding Proteins: Relevance to Alzheimer’s Disease?

  2014cites this paper
• Expression of mannose receptors in breast carcinomas using garlic lectin

  2013cites this paper
• Combinatorial peptide libraries to overcome the classical affinity-enrichment methods in proteomics

  2013cites this paper
• Current Low-Abundance Protein Access

  2013cites this paper
• Qualitative and quantitative assessment on the use of magnetic nanoparticles for glycopeptide enrichment.

  2013cites this paper
• Glycomics of pediatric and adulthood diseases of the central nervous system.

  2012cites this paper
• Mass spectrometry-based proteomics and peptidomics for systems biology and biomarker discovery

  2012cites this paper
• Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells

  2012influential citation
• The secretory lectin ZG16p

  2011cites this paper
• Pancreatic zymogen granules: new proteins in unexpected places

  2011cites this paper
• Characterization of the human submandibular/sublingual saliva glycoproteome using lectin affinity chromatography coupled to multidimensional protein identification technology.

  2011cites this paper
• Synthesis and optimization of lectin functionalized nanoprobes for the selective recovery of glycoproteins from human body fluids.

  2011cites this paper